Registered number
09192973
OJUMED PHARMA LIMITED
Filleted Accounts
31 August 2021
OJUMED PHARMA LIMITED
Registered number: 09192973
Balance Sheet
as at 31 August 2021
Notes 2021 2020
£ £
Current assets
Cash at bank and in hand 64,445 28,261
Creditors: amounts falling due within one year 3 (55,333) (15,165)
Net current assets 9,112 13,096
Net assets 9,112 13,096
Capital and reserves
Called up share capital 100 100
Profit and loss account 9,012 12,996
Shareholder's funds 9,112 13,096
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Deepak Gupta
Director
Approved by the board on 27 August 2022
OJUMED PHARMA LIMITED
Notes to the Accounts
for the year ended 31 August 2021
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2021 2020
Number Number
Average number of persons employed by the company 1 1
3 Creditors: amounts falling due within one year 2021 2020
£ £
Taxation and social security costs - 11,259
Other creditors 55,333 3,906
55,333 15,165
4 Other information
OJUMED PHARMA LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
103 Lillibrooke Crescent
Maidenhead
Berkshire
United Kingdom
SL6 3XL
OJUMED PHARMA LIMITED 09192973 false 2020-09-01 2021-08-31 2021-08-31 VT Final Accounts March 2021 Mr Deepak Gupta No description of principal activity 09192973 2019-09-01 2020-08-31 09192973 core:WithinOneYear 2020-08-31 09192973 core:ShareCapital 2020-08-31 09192973 core:RetainedEarningsAccumulatedLosses 2020-08-31 09192973 2020-09-01 2021-08-31 09192973 bus:PrivateLimitedCompanyLtd 2020-09-01 2021-08-31 09192973 bus:AuditExempt-NoAccountantsReport 2020-09-01 2021-08-31 09192973 bus:Director40 2020-09-01 2021-08-31 09192973 1 2020-09-01 2021-08-31 09192973 2 2020-09-01 2021-08-31 09192973 countries:England 2020-09-01 2021-08-31 09192973 bus:FRS102 2020-09-01 2021-08-31 09192973 bus:FullAccounts 2020-09-01 2021-08-31 09192973 2021-08-31 09192973 core:WithinOneYear 2021-08-31 09192973 core:ShareCapital 2021-08-31 09192973 core:RetainedEarningsAccumulatedLosses 2021-08-31 09192973 2020-08-31 iso4217:GBP xbrli:pure